Filing Details
VivoSim Labs, INC. (NASDAQ:VIVS) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event.
8k filedNASDAQ:VIVS
VivoSim Labs, INC. (VIVS) Reports Material Event to SEC
Filing Details VivoSim Labs, INC. (NASDAQ:VIVS) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event. Market Context VivoSim…
Market Context
VivoSim Labs, INC.'s stock currently trades at $0.58 with a market capitalization of $5.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for VivoSim Labs, INC.'s stock.
All SEC filings for VivoSim Labs, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View VIVS Stock Page
Frequently Asked Questions
Where can I read VIVS's SEC filings?
Browse all filings on our VIVS SEC filings page.
What types of SEC filings does VivoSim Labs, INC. file?
Public companies like VivoSim Labs, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.